Plan B Pharmacy Access Movement Likely To Be Further Fueled By FDA Delay
This article was originally published in The Tan Sheet
Executive Summary
State legislative efforts to make Barr's Plan B available directly from pharmacists will likely increase following FDA's latest deferral of a decision on the Rx-to-OTC switch of the drug
You may also be interested in...
Barr Foresees Plan B OTC Launch In The Fall Pending “Approvable” Status
Barr Labs expects its Plan B (levonorgestrel) emergency contraceptive to hit the market as an OTC by September at the earliest, assuming FDA says the product is approvable by the May 21 PDUFA deadline
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands